BBI - Brickell Biotech regains Nasdaq compliance for minimum bid price requirement
- Brickell Biotech ( NASDAQ: BBI ) was notified by Nasdaq that it has regained compliance with the minimum bid price requirement for continued listing on Nasdaq.
- The stock will continue to be listed and traded on the exchange.
- Shares trading 1.4% higher premarket.
For further details see:
Brickell Biotech regains Nasdaq compliance for minimum bid price requirement